- Home
- RYTM vs PTON Comparison
RYTM vs PTON Comparison
Compare RYTM & PTON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- PTON
- Stock Information
- Founded
- RYTM 2008
- PTON 2012
- Country
- RYTM United States
- PTON United States
- Employees
- RYTM N/A
- PTON N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- PTON Recreational Games/Products/Toys
- Sector
- RYTM Health Care
- PTON Consumer Discretionary
- Exchange
- RYTM Nasdaq
- PTON Nasdaq
- Market Cap
- RYTM 3.1B
- PTON 3.6B
- IPO Year
- RYTM 2017
- PTON 2019
- Fundamental
- Price
- RYTM $57.07
- PTON $8.42
- Analyst Decision
- RYTM Strong Buy
- PTON Hold
- Analyst Count
- RYTM 10
- PTON 19
- Target Price
- RYTM $66.90
- PTON $6.58
- AVG Volume (30 Days)
- RYTM 549.1K
- PTON 10.7M
- Earning Date
- RYTM 02-20-2025
- PTON 01-30-2025
- Dividend Yield
- RYTM N/A
- PTON N/A
- EPS Growth
- RYTM N/A
- PTON N/A
- EPS
- RYTM N/A
- PTON N/A
- Revenue
- RYTM $112,530,000.00
- PTON $2,690,700,000.00
- Revenue This Year
- RYTM $63.77
- PTON N/A
- Revenue Next Year
- RYTM $44.91
- PTON $1.19
- P/E Ratio
- RYTM N/A
- PTON N/A
- Revenue Growth
- RYTM 81.55
- PTON N/A
- 52 Week Low
- RYTM $35.17
- PTON $2.70
- 52 Week High
- RYTM $68.58
- PTON $10.90
- Technical
- Relative Strength Index (RSI)
- RYTM 52.43
- PTON 43.01
- Support Level
- RYTM $52.71
- PTON $8.12
- Resistance Level
- RYTM $60.12
- PTON $9.28
- Average True Range (ATR)
- RYTM 2.11
- PTON 0.52
- MACD
- RYTM -0.00
- PTON -0.09
- Stochastic Oscillator
- RYTM 58.93
- PTON 18.41
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.
About PTON Peloton Interactive Inc.
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of bike and tread and related accessories sales, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue is generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates maximum revenue from the Subscription segment. Geographically, the company derives a majority of its revenue from North America and the rest from the International markets.